Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases
- 16 February 2006
- Vol. 55 (7) , 1058-1059
- https://doi.org/10.1136/gut.2005.090571
Abstract
Patients undergoing liver resection of CRC liver metastases were enrolled if diagnostic MRI identified a single metastasis greater than 1.5 cm in diameter that was not adjacent to a major vessel. Other inclusion/exclusion criteria were as described previously.1 A detailed description of the DCE-MRI technique using gadolinium-diethylenetriaminepenta-acetic acid (Gd-DTPA) is available from the corresponding author. Tumour vascularity was measured according to Cancer Research UK Pharmacodynamic/Pharmacokinetic Technologies Advisory Committee recommendations.3 The initial area under the Gd-DTPA concentration-time curve at 60 seconds (IAUGC in mmol/l×s) was determined and the concentration-time curve was fitted to the Tofts model4 in order to calculate the transfer constant Ktrans (the permeability-surface area product/second), using an aortic arterial input function.Keywords
This publication has 10 references indexed in Scilit:
- Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressorsProceedings of the National Academy of Sciences, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over timeJournal of Magnetic Resonance Imaging, 2004
- Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsThe British Journal of Radiology, 2003
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I StudiesJournal of Clinical Oncology, 2003
- The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastasesPublished by Elsevier ,2003
- Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastasesJournal of Magnetic Resonance Imaging, 2003
- Divergent effects of new cyclooxygenase inhibitors on gastric ulcer healing: Shifting the angiogenic balanceProceedings of the National Academy of Sciences, 2002
- Breath‐hold perfusion and permeability mapping of hepatic malignancies using magnetic resonance imaging and a first‐pass leakage profile modelNMR in Biomedicine, 2002
- Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbolsJournal of Magnetic Resonance Imaging, 1999